Application effect of Suhexiang after PCI in patients with mild cognitive dysfunction complicating acute ST-elevation myocardial infarction
10.3969/j.issn.1671-8348.2024.14.012
- VernacularTitle:苏合香在轻度认知功能障碍合并急性ST段抬高型心肌梗死患者PCI术后的应用效果研究
- Author:
Shuo WANG
1
;
Shanshan HAN
;
Huan YANG
;
Liu LI
;
Shuiling WANG
;
Qincong CHEN
Author Information
1. 石家庄市人民医院心内科,石家庄 050031
- Keywords:
Suhexiang;
acute ST-elevation myocardial infarction;
percutaneous coronary intervention;
mild cognitive impairment
- From:
Chongqing Medicine
2024;53(14):2143-2147
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the application effect of Suhexiang after PCI in the patients with mild cognitive impairment(MCI) complicating acute ST-elevation myocardial infarction.Methods A total of 100 inpatients with MCI complicating acute ST-elevation myocardial infarction in Shijiazhuang People's Hospital were selected and divided into the control group and Suhexiang group according to the random number table method,50 cases in each group.The control group was given the clinical routine treatment of coronary heart disease PCI,and the Suhexiang group was added with Suhexiang 1 g once daily on the basis of the control group,and the course of treatment was 1 month.Each patient conducted the coronary arterial SYNTAXⅡ sco-ring.Resting D-SPECT+regadenoson loaded D-SPECT was used to evaluate the number of myocardial ische-mia total segments,left ventricular ejection fraction,total myocardial perfusion score on 7 d and in 3 months after PCI,MMSE and MoCA were used to evaluate the cognitive impairment on 7 d and in 3 months after PCI,and the adverse drug reactions occurrence in 3 months after PCI was recorded.Results There was no statistically significant difference in MMSE,MoCA,left ventricular ejection fraction,number of myocardial is-chemia segments,and myocardial perfusion total score on 7 d after PCI between the two groups (P>0.05). The MMSE,MoCA,left ventricular ejection fraction,number of myocardial ischemia segments and total myo-cardial perfusion score in 3 months after PCI in the Suhexiang group were significantly better than those in the control group,and the difference was statistically significant (P<0.05).There was no statistically significant difference in adverse reactions between the two groups (P>0.05).Conclusion Suhexiang could significantly improve the myocardial perfusion,cardiac function and cognitive function after PCI in the patients with MCI complicating acute ST-elevation myocardial infarction,but does not increase adverse reactions.
